Atlas Trials

Al18F-NOTA-octreotide PET Imaging of the Somatostatin Receptor in Neuroendocrine Tumors

Clinical trial NCT03883776 · COMPLETED

Trial details

NCT number
NCT03883776
Sponsor
Universitaire Ziekenhuizen KU Leuven
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Neuroendocrine Tumors
Start date
2019-04-11
Primary completion
2019-10-29
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.